PRTC

$0.00

(

+0.00%

)
Quote details

stock

PureTech Health PLC

NASDAQ | PRTC

16.96

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$386.69M

Market Cap

9.41

P/E Ratio

1.7

EPS

$23.69

52 Week High

$13.30

52 Week Low

HEALTHCARE

Sector

PRTC Chart

Recent Chart
Price Action

PRTC Technicals

Tags:

PRTC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.3M
Total Revenue $4.8M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$136M
Selling General And Administrative $27M
Research And Development $54M
Operating Expenses $140M
Investment Income Net -
Net Interest Income $13M
Interest Income $23M
Interest Expense $10M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.6M
Income Before Tax $24M
Income Tax Expense -$4M
Interest And Debt Expense -
Net Income From Continuing Operations $28M
Comprehensive Income Net Of Tax -
Ebit $34M
Ebitda $37M
Net Income $54M

Revenue & Profitability

Earnings Performance

PRTC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $603M
Total Current Assets $386M
Cash And Cash Equivalents At Carrying Value $281M
Cash And Short Term Investments $281M
Inventory -
Current Net Receivables $13M
Total Non Current Assets $216M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $601K
Intangible Assets Excluding Goodwill $601K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $87M
Other Current Assets $6M
Other Non Current Assets -
Total Liabilities $195M
Total Current Liabilities $41M
Current Accounts Payable $5.5M
Deferred Revenue -
Current Debt -
Short Term Debt $7.7M
Total Non Current Liabilities $153M
Capital Lease Obligations $18M
Long Term Debt -
Current Long Term Debt $4.1M
Long Term Debt Noncurrent -
Short Long Term Debt Total $22M
Other Current Liabilities $28M
Other Non Current Liabilities $137M
Total Shareholder Equity $415M
Treasury Stock -
Retained Earnings $32M
Common Stock $4.9M
Common Stock Shares Outstanding $27M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$134M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.6M
Capital Expenditures $11K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $241M
Cashflow From Financing -$17M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$108M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $28M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.3M
Total Revenue $4.8M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$136M
Selling General And Administrative $27M
Research And Development $54M
Operating Expenses $140M
Investment Income Net -
Net Interest Income $13M
Interest Income $23M
Interest Expense $10M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.6M
Income Before Tax $24M
Income Tax Expense -$4M
Interest And Debt Expense -
Net Income From Continuing Operations $28M
Comprehensive Income Net Of Tax -
Ebit $34M
Ebitda $37M
Net Income $54M

PRTC News

PRTC Profile

PureTech Health PLC Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

PureTech Health PLC is a leading Boston-based clinical-stage biotherapeutics company focused on developing groundbreaking therapies for a range of challenging diseases, including inflammatory disorders, fibrotic conditions, and various cancers impacting lymphatic and gastrointestinal systems. The company is distinguished by its innovative research platform and a robust pipeline of drug candidates, supported by strategic partnerships to meet substantial unmet medical needs. With a strong emphasis on addressing neurological and neuropsychological disorders, PureTech is poised to deliver transformative medical solutions on a global scale, solidifying its position as a pioneer in the biopharmaceutical industry.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+51.88%
$1.61
VINE
+10.76%
$0.39
NVDA
-1.80%
$177.00
AMZE
+19.82%
$0.47
TLRY
-22.27%
$0.80
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
INTC
+9.08%
$40.15
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
TSLA
+1.71%
$426.58
BYND
-4.59%
$0.97
BMNR
+4.53%
$33.18
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
CLSK
+11.97%
$15.06
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
INHD
-0.97%
$0.22
BIYA
+10.67%
$0.27
SRM
+53.27%
$10.30
ONMD
+30.28%
$1.85
CHR
-2.55%
$0.04
SNAP
+0.37%
$7.63
WULF
+4.51%
$15.51
BULL
+6.43%
$9.26
F
+0.45%
$13.25
TWOH
0.00%
$0.00
BMNU
+3.72%
$7.79
CIFR
+7.41%
$20.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
MARA
+4.18%
$11.57
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
ONDS
-4.36%
$7.88
NIO
+1.09%
$5.51
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
AFMD
-34.94%
$0.18
DEFT
+9.24%
$1.51
APLD
+5.05%
$24.94
BTBT
+1.15%
$2.34
KWM
+17.30%
$0.77
RIOT
+7.82%
$16.13
GOOGL
-0.26%
$319.09
PFE
0.00%
$25.71
SMX
+244.97%
$60.02
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
CRCL
+9.28%
$79.38
AIIO
-9.09%
$0.70
GOOG
-0.05%
$320.12
VEEE
+45.50%
$2.59
IREN
-1.32%
$47.81
GRYP
-10.38%
$1.38
DVLT
-7.05%
$1.97
HBI
-2.20%
$6.44
ACHR
+4.79%
$7.84
MODV
-25.22%
$0.43
BAC
+1.28%
$53.67
AMD
+1.53%
$217.53
AMCR
+1.29%
$8.62
RIVN
+4.20%
$16.86
IBRX
+9.15%
$2.32
CAN
+10.07%
$1.01
GRAB
+2.34%
$5.44
AG
+12.47%
$15.19
CDE
+6.76%
$17.28
NGD
+5.92%
$8.30
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
KDLY
+7.20%
$0.49
DNN
+0.39%
$2.57
T
+0.69%
$26.00
YCBD
-3.44%
$0.53
NVO
+1.21%
$49.30
CRCA
+17.43%
$4.32
AMC
+5.99%
$2.43
TMC
+17.92%
$6.87
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
RIG
+1.97%
$4.38
CRWV
-1.57%
$73.12
SHOT
-74.37%
$0.39
RGTI
0.00%
$25.57
ZAPP
-46.30%
$0.15
MSFT
+1.34%
$492.01
BTE
+2.05%
$3.22
SMR
+4.38%
$19.87
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+51.88%
$1.61
VINE
+10.76%
$0.39
NVDA
-1.80%
$177.00
AMZE
+19.82%
$0.47
TLRY
-22.27%
$0.80
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
INTC
+9.08%
$40.15
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
TSLA
+1.71%
$426.58
BYND
-4.59%
$0.97
BMNR
+4.53%
$33.18
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
CLSK
+11.97%
$15.06
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
INHD
-0.97%
$0.22
BIYA
+10.67%
$0.27
SRM
+53.27%
$10.30
ONMD
+30.28%
$1.85
CHR
-2.55%
$0.04
SNAP
+0.37%
$7.63
WULF
+4.51%
$15.51
BULL
+6.43%
$9.26
F
+0.45%
$13.25
TWOH
0.00%
$0.00
BMNU
+3.72%
$7.79
CIFR
+7.41%
$20.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
MARA
+4.18%
$11.57
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
ONDS
-4.36%
$7.88
NIO
+1.09%
$5.51
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
AFMD
-34.94%
$0.18
DEFT
+9.24%
$1.51
APLD
+5.05%
$24.94
BTBT
+1.15%
$2.34
KWM
+17.30%
$0.77
RIOT
+7.82%
$16.13
GOOGL
-0.26%
$319.09
PFE
0.00%
$25.71
SMX
+244.97%
$60.02
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
CRCL
+9.28%
$79.38
AIIO
-9.09%
$0.70
GOOG
-0.05%
$320.12
VEEE
+45.50%
$2.59
IREN
-1.32%
$47.81
GRYP
-10.38%
$1.38
DVLT
-7.05%
$1.97
HBI
-2.20%
$6.44
ACHR
+4.79%
$7.84
MODV
-25.22%
$0.43
BAC
+1.28%
$53.67
AMD
+1.53%
$217.53
AMCR
+1.29%
$8.62
RIVN
+4.20%
$16.86
IBRX
+9.15%
$2.32
CAN
+10.07%
$1.01
GRAB
+2.34%
$5.44
AG
+12.47%
$15.19
CDE
+6.76%
$17.28
NGD
+5.92%
$8.30
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
KDLY
+7.20%
$0.49
DNN
+0.39%
$2.57
T
+0.69%
$26.00
YCBD
-3.44%
$0.53
NVO
+1.21%
$49.30
CRCA
+17.43%
$4.32
AMC
+5.99%
$2.43
TMC
+17.92%
$6.87
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
RIG
+1.97%
$4.38
CRWV
-1.57%
$73.12
SHOT
-74.37%
$0.39
RGTI
0.00%
$25.57
ZAPP
-46.30%
$0.15
MSFT
+1.34%
$492.01
BTE
+2.05%
$3.22
SMR
+4.38%
$19.87

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.